FDA gives green light to innovative device for liver conditions

New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC

MHRA urges caution over illegal medicines from beauty salons and social media

First patient dosed in landmark trial for GAD treatment

New CT-guided radiotherapy system offers personalised cancer treatment

New treatment could revolutionise care for HAE patients

Phase 2a study shows promising antidepressant effects

Trial explores potential of therapy in treating multiple cancer types

Promising trial results support marketing authorisation application

Successful phase 1 study highlights potential of roginolisib